Inactivation of median preoptic nucleus causes c-Fos expression in hypocretin- and serotonin-containing neurons in anesthetized rat

Brain Res. 2008 Oct 9:1234:66-77. doi: 10.1016/j.brainres.2008.07.115. Epub 2008 Aug 8.

Abstract

The median preoptic nucleus (MnPN) of the hypothalamus contains sleep-active neurons including sleep-active GABAergic neurons and is involved in the regulation of nonREM/REM sleep. The hypocretinergic (HCRT) neurons of the perifornical-lateral hypothalamic area (PF-LHA) and serotonergic (5-HT) neurons of the dorsal raphe nucleus (DRN) are mostly active during waking and have been implicated in the regulation of arousal. MnPN GABAergic neurons project to the PF-LHA and DRN. It is hypothesized that MnPN promotes sleep by inhibiting multiple arousal systems including HCRT and other wake-active neurons within the PF-LHA and 5-HT neurons in the DRN. We examined the effects of inactivation of MnPN neurons by locally microinjecting 0.2 microl of 1 mM or 10 mM solutions of a GABA(A) receptor agonist, muscimol, into the MnPN on Fos expression (Fos-IR) in the PF-LHA neurons including HCRT neurons and 5-HT neurons in the DRN in anesthetized rats. Compared to artificial cerebrospinal fluid control, microinjection of muscimol into the MnPN resulted in significantly higher percentages of HCRT and non-HCRT neurons in the PF-LHA and 5-HT neurons in the DRN that exhibited Fos-IR. The percentage of melanin-concentrating hormone (MCH)+/Fos+ neurons in the PF-LHA did not change after muscimol treatments. These results support a hypothesis that the activation of MnPN neurons contributes to the suppression of wake-promoting systems including HCRT and other unidentified neurons in the PF-LHA and 5-HT neurons in the DRN. These results also suggest that MCH neurons may not be under MnPN inhibitory control. These findings are consistent with a hypothesized role of MnPN in sleep regulation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Anesthesia
  • Animals
  • Arousal / physiology
  • Cell Count
  • GABA Agonists / administration & dosage
  • GABA Agonists / pharmacology
  • GABA-A Receptor Agonists
  • Gene Expression Regulation / physiology*
  • Genes, fos / physiology*
  • Glutamate Decarboxylase / metabolism
  • Hypothalamic Area, Lateral / physiology
  • Hypothalamic Hormones / metabolism
  • Immunohistochemistry
  • Intracellular Signaling Peptides and Proteins / metabolism
  • Intracellular Signaling Peptides and Proteins / physiology*
  • Male
  • Melanins / metabolism
  • Microinjections
  • Muscimol / administration & dosage
  • Muscimol / pharmacology
  • Neurons / metabolism*
  • Neuropeptides / metabolism
  • Neuropeptides / physiology*
  • Orexin Receptors
  • Orexins
  • Pituitary Hormones / metabolism
  • Preoptic Area / physiology*
  • Raphe Nuclei / physiology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, G-Protein-Coupled / metabolism
  • Receptors, Neuropeptide / metabolism
  • Serotonin / metabolism
  • Serotonin / physiology*

Substances

  • GABA Agonists
  • GABA-A Receptor Agonists
  • Hypothalamic Hormones
  • Intracellular Signaling Peptides and Proteins
  • Melanins
  • Neuropeptides
  • Orexin Receptors
  • Orexins
  • Pituitary Hormones
  • Receptors, G-Protein-Coupled
  • Receptors, Neuropeptide
  • Muscimol
  • Serotonin
  • melanin-concentrating hormone
  • Glutamate Decarboxylase